Shanghai Kechow Pharma, Inc.
PrivateLast Round
Series D
Sep 1, 2023
Total Funding Raised
$75.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shanghai Kechow Pharma, Inc. is a pharmaceutical company that integrates drug discovery, clinical development, and sales of new anti-cancer drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Kechow Pharma, Inc. Comparables
Compare Shanghai Kechow Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABM Therapeutics | 76% | |
| Dizal Pharmaceutical | 74% | |
| Zai Lab Limited | 74% |
Shanghai Kechow Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2023 | ||||
| Series C Extension | Jul 1, 2022 | ||||
| Series C Extension | Nov 1, 2021 | ||||
| Series C | Dec 13, 2019 | ||||
| Series B | Jul 1, 2018 | ||||
Series A | Feb 1, 2016 |
Shanghai Kechow Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series A |
| 德同资本 | Series D |
| Grains Valley Venture Capital | Series A |
| 5Y Capital | Angel |
| China Merchants Capital | Series C Extension |
| SDIC Venture Capital | Series B |
| 荷塘创投 | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 2108% MoM, from 53 to 1.2K.
- Jun 15, 2026
Open roles increased from 0 to 7, representing 175% of headcount.
Shanghai Kechow Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Kechow Pharma, Inc.'s valuation, stock price, and market status.
Is Shanghai Kechow Pharma, Inc. a public or private company?
Shanghai Kechow Pharma, Inc. is a private company.
What is the current stock price of Shanghai Kechow Pharma, Inc.?
Shanghai Kechow Pharma, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Shanghai Kechow Pharma, Inc. worth (valuation)?
Valuation information for Shanghai Kechow Pharma, Inc. is not publicly available.
Can I buy Shanghai Kechow Pharma, Inc. stock?
Shanghai Kechow Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Kechow Pharma, Inc.'s last funding round?
Shanghai Kechow Pharma, Inc.'s most recent funding round was Series C on December 13, 2019.
Who are the main investors in Shanghai Kechow Pharma, Inc.?
Key investors in Shanghai Kechow Pharma, Inc. include Decheng Capital.
Will Shanghai Kechow Pharma, Inc. IPO soon?
No public IPO plans have been announced for Shanghai Kechow Pharma, Inc..
How can I track Shanghai Kechow Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Kechow Pharma, Inc.'s secondary market activity and sign up for updates.